Cargando…

NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells

Recently, the human gene NOTCH1 has been found to be implicated in cancer cell metastasis and the maintenance of cancer stem cells. However, for breast cancer in particular, an association between NOTCH1 levels and metastasis has not been determined. In this study, we investigated the expression sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Ying, Shen, Songjie, Zhou, Yidong, Mao, Feng, Lin, Yan, Guan, Jinghong, Xu, Yali, Zhang, Shu, Liu, Xu, Sun, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106235/ https://www.ncbi.nlm.nih.gov/pubmed/27853380 http://dx.doi.org/10.2147/OTT.S109606

Ejemplares similares

Concurrent administration of trastuzumab and anthracyclines as adjuvant regimen for HER2-positive breast cancer: a randomised controlled trial
por: Shen, Songjie, et al.
Publicado: (2017)

TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
por: Xu, Qianqian, et al.
Publicado: (2016)

Breast-conserving surgery without axillary surgery and radiation versus mastectomy plus axillary dissection in elderly breast cancer patients: A retrospective study
por: Zhong, Ying, et al.
Publicado: (2023)

Omitting radiotherapy is safe in breast cancer patients ≥ 70 years old after breast-conserving surgery without axillary lymph node operation
por: Zhong, Ying, et al.
Publicado: (2020)

Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse
por: Zhong, Ying, et al.
Publicado: (2013)

Predictors of nonsentinel lymph node metastasis in patients with breast cancer with metastasis in the sentinel node
por: Zhou, Yidong, et al.
Publicado: (2019)

GnRHa for Ovarian Protection and the Association between AMH and Ovarian Function during Adjuvant Chemotherapy for Breast Cancer
por: Zhong, Ying, et al.
Publicado: (2019)

Insulin-like growth factor 2 receptor is a key immune-related gene that is correlated with a poor prognosis in patients with triple-negative breast cancer: A bioinformatics analysis
por: Zhong, Ying, et al.
Publicado: (2022)

Mammographic casting-type calcification is an independent prognostic factor in invasive breast cancer
por: Li, Yan, et al.
Publicado: (2019)

A nomogram for individually predicting overall survival for elderly patients with early breast cancer: a consecutive cohort study
por: Zhong, Ying, et al.
Publicado: (2023)

The influence on survival of delay in the treatment initiation of screening detected non-symptomatic breast cancer
por: Li, Yan, et al.
Publicado: (2019)

Cancer-derived exosomal miR-7641 promotes breast cancer progression and metastasis
por: Shen, Songjie, et al.
Publicado: (2021)

Phosphatidylinositol-3,4,5-Trisphosphate Dependent Rac Exchange Factor 1 (PREX1) is a Novel Predictor of Prognosis for Breast Cancer Patients: A Retrospective Case Series
por: Zhong, Ying, et al.
Publicado: (2019)

Clinical characteristics and survival outcomes of patients with both primary breast cancer and primary ovarian cancer
por: Chen, Chang, et al.
Publicado: (2020)

Syndecan-1 as an immunogene in Triple-negative breast cancer: regulation tumor-infiltrating lymphocyte in the tumor microenviroment and EMT by TGFb1/Smad pathway
por: Zhong, Ying, et al.
Publicado: (2023)

The Diagnostic Performance of Minimally Invasive Biopsy in Predicting Breast Pathological Complete Response After Neoadjuvant Systemic Therapy in Breast Cancer: A Meta-Analysis
por: Li, Yan, et al.
Publicado: (2020)

Expression and function of MutT homolog 1 in distinct subtypes of breast cancer
por: Zhang, Xiaohui, et al.
Publicado: (2017)

Ultrasound-Assisted Thoracic Paravertebral Block Reduces Intraoperative Opioid Requirement and Improves Analgesia after Breast Cancer Surgery: A Randomized, Controlled, Single-Center Trial
por: Pei, Lijian, et al.
Publicado: (2015)

Rationale and design of a phase II trial of pyrotinib in combination with nab-paclitaxel as adjuvant therapy for N0/N1mi, HER2 + early breast cancer (PHAEDRA)
por: Wang, Changjun, et al.
Publicado: (2022)

miR-452 Reverses Abnormal Glycosylation Modification of ERα and Estrogen Resistance in TNBC (Triple-Negative Breast Cancer) Through Targeting UGT1A1
por: Li, Yan, et al.
Publicado: (2020)

Comparison of ultrasound and mammography for early diagnosis of breast cancer among Chinese women with suspected breast lesions: A prospective trial
por: Wang, Yingjiao, et al.
Publicado: (2022)

Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for HER2 positive and hormone receptor positive metastatic or locally advanced breast cancer: study protocol of a randomized controlled trial
por: Wang, Changjun, et al.
Publicado: (2020)

The Prognostic Value of the Age-Adjusted Charlson Comorbidity Index Among the Elderly with Breast Cancer
por: Wang, Zhe, et al.
Publicado: (2023)

lncRNA AFAP1-AS1 promotes triple negative breast cancer cell proliferation and invasion via targeting miR-145 to regulate MTH1 expression
por: Zhang, Xiaohui, et al.
Publicado: (2020)

Diagnostic Performance of Indocyanine Green-Guided Sentinel Lymph Node Biopsy in Breast Cancer: A Meta-Analysis
por: Zhang, Xiaohui, et al.
Publicado: (2016)

Comparison of CTS5 risk model and 21-gene recurrence score assay in large-scale breast cancer population and combination of CTS5 and recurrence score to develop a novel nomogram for prognosis prediction
por: Wang, Changjun, et al.
Publicado: (2022)

Efficacy and Safety of Anti-HER2 Agents in Combination With Chemotherapy for Metastatic HER2-Positive Breast Cancer Patient: A Network Meta-Analysis
por: Zhang, Xiaohui, et al.
Publicado: (2021)

A Prognostic Model of Triple-Negative Breast Cancer Based on miR-27b-3p and Node Status
por: Shen, Songjie, et al.
Publicado: (2014)

Association of striking life events with primary breast cancer in 265 Chinese women: a case-control study
por: Lin, Yan, et al.
Publicado: (2017)

Long-term survival of screen-detected synchronous and metachronous bilateral non-palpable breast cancer among Chinese women: a hospital-based study (2003–2017)
por: Pan, Bo, et al.
Publicado: (2022)

Identification of Potential Key Genes Associated With the Pathogenesis, Metastasis, and Prognosis of Triple-Negative Breast Cancer on the Basis of Integrated Bioinformatics Analysis
por: Zhao, Bin, et al.
Publicado: (2020)

A case report of primary angiosarcoma of the breast
por: Huang, Junying, et al.
Publicado: (2023)

Validation of CTS5 model in large-scale breast cancer population and the impact of menopausal and HER2 status on its prognostic value
por: Wang, Changjun, et al.
Publicado: (2020)

Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysis
por: Wang, Changjun, et al.
Publicado: (2016)

The impact of pre-existed and SERM-induced non-alcoholic fatty liver disease on breast cancer survival: a meta-analysis
por: Wang, Changjun, et al.
Publicado: (2020)

Would 1.0 cm be a more suitable cutoff to subdivide pT1 tumors in hormone receptor‐negative and HER2‐positive breast cancer?
por: Wang, Changjun, et al.
Publicado: (2018)

Web-Based Medical Information Searching by Chinese Patients With Breast Cancer and its Influence on Survival: Observational Study
por: Li, Yan, et al.
Publicado: (2020)

Long noncoding RNA AFAP1-AS1 promotes tumor progression and invasion by regulating the miR-2110/Sp1 axis in triple-negative breast cancer
por: Zhang, Xiaohui, et al.
Publicado: (2021)

Notch1 activation is a poor prognostic factor in patients with gastric cancer
por: Zhang, H, et al.
Publicado: (2014)

Heterogeneity of breast cancer stem cells as evidenced with Notch-dependent and Notch-independent populations
por: Wong, Nelson K Y, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_388o04tcamj5k40iidndbvvidt